Floatz logo

Therapeutic Asset Ratings

1,133 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
NADOLOL
Leukemia
University of ArizonaEarly P1C (34)
NADOLOL
Lymphoma
University of ArizonaEarly P1C (34)
Nelitolimod
Metastatic Malignant Neoplasm In The Colon
Northwell HealthEarly P1C (34)
Nitrogen
Major Depressive Disorder
Massachusetts General HospitalEarly P1C (34)
nk042
Multiple Sclerosis
The Affiliated Hospital of Xuzhou Medical UniversityEarly P1C (34)
nk510
Non-Small Cell Lung Carcinoma
Base Therapeutics (Shanghai) Co., Ltd.Early P1C (34)
NOS
Alzheimer Disease
University of PennsylvaniaEarly P1C (34)
NOS
Parkinson Disease
University of PennsylvaniaEarly P1C (34)
Omnipaque
HER2 Positive Breast Carcinoma
Alison StopeckEarly P1C (34)
Omnipaque
Triple-Negative Breast Carcinoma
Alison StopeckEarly P1C (34)
Panitumumab-Irdye800
Glioblastoma
Eben RosenthalEarly P1C (34)
Pba-0111
Head And Neck Squamous Cell Carcinoma
Pure Biologics S.A.Early P1C (34)
Pba-0111
Triple-Negative Breast Carcinoma
Pure Biologics S.A.Early P1C (34)
Perampanel
Glioblastoma
Aarhus University HospitalEarly P1C (34)
Posaconazole
Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (34)
prg2302
Acute Lymphoblastic Leukemia
Tan JieEarly P1C (34)
qt-019c
Multiple Sclerosis
Tianjin Huanhu HospitalEarly P1C (34)
R130
Fallopian Tube Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Gastric Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Liver Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Lung Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Melanoma
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Non-Small Cell Lung Carcinoma
Shanghai Yunying Medical TechnologyEarly P1C (34)
R130
Small Cell Lung Carcinoma
Shanghai Yunying Medical TechnologyEarly P1C (34)
rd133
Cancer
Tongji HospitalEarly P1C (34)
Showing 876 to 900 of 1,133 assets
PreviousPage 36 of 46Next